Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Homo sapiens | WIG | Richard A Young | |||||
GSE154999 |
Retinoic acid rewires the adrenergic core regulatory circuitry of neuroblastoma but can be subverted by enhancer hijacking of MYC or MYCN (ChIP-Seq)
|
21 |
|
Richard A Young | Oct 25, 2021 | |||
GSE155002 |
Retinoic acid rewires the adrenergic core regulatory circuitry of neuroblastoma but can be subverted by enhancer hijacking of MYC or MYCN
|
49 | Richard A Young | Oct 25, 2021 | ||||
GSE152885 |
Predicting master transcription factors from pan-cancer expression data
|
24 |
|
Richard A Young | Sep 15, 2021 | |||
GSE149085 |
Partitioning of cancer therapeutics in nuclear condensates
|
5 |
|
Richard A Young | Apr 27, 2020 | |||
GSE115465 |
JDP2 - an Oncogenic bZIP Transcription Factor in T-cell Acute Lymphoblastic Leukemia [ChIP-Seq]
|
2 |
|
Richard A Young | Jun 18, 2018 | |||
GSE115466 |
JDP2 - an Oncogenic bZIP Transcription Factor in T-cell Acute Lymphoblastic Leukemia
|
14 |
|
Richard A Young | Jun 18, 2018 | |||
GSE94822 |
Super-enhancer Driven Core Regulatory Circuitry in MYCN-amplified Neuroblastoma [ChIP-Seq]
|
16 |
|
Richard A Young | May 22, 2018 | |||
GSE94823 |
Super-enhancer Driven Core Regulatory Circuitry in MYCN-amplified Neuroblastoma [ATAC-Seq]
|
2 |
|
Richard A Young | May 22, 2018 | |||
GSE94824 |
Super-enhancer Driven Core Regulatory Circuitry in MYCN-amplified Neuroblastoma
|
30 | Richard A Young | May 22, 2018 | ||||
GSE102684 |
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 [ChIP-seq II]
|
18 |
|
Richard A Young | Feb 16, 2018 | |||
GSE101294 |
c-MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification (ATAC-Seq)
|
3 |
|
Richard A Young | Dec 22, 2017 | |||
GSE101295 |
c-MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification (ChIP-Seq)
|
12 |
|
Richard A Young | Dec 22, 2017 | |||
GSE101297 |
c-MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification
|
|
27 |
|
Richard A Young | Dec 22, 2017 | ||
GSE99518 |
YY1 is a structural regulator of enhancer-promoter loops [ChIP-Seq]
|
|
4 |
|
Richard A Young | Nov 16, 2017 | ||
GSE99521 |
YY1 is a structural regulator of enhancer-promoter loops
|
|
47 | Richard A Young | Nov 16, 2017 | |||
GSE75814 |
CDK7 Inhibition Suppresses Melanoma Growth By Depleting A Super-enhancer Associated "Achilles" Lineage Cluster [ChIP-Seq]
|
6 |
|
Richard A Young | Oct 23, 2017 | |||
GSE75820 |
CDK7 Inhibition Suppresses Melanoma Growth By Depleting A Super-enhancer Associated "Achilles" Lineage Cluster
|
14 |
|
Richard A Young | Oct 23, 2017 | |||
GSE89128 |
Suppression of adaptive responses to targeted cancer therapy by transcriptional repression [ChIP-seq]
|
76 |
|
Richard A Young | Oct 23, 2017 | |||
GSE89129 |
Suppression of adaptive responses to targeted cancer therapy by transcriptional repression
|
166 | Richard A Young | Oct 23, 2017 | ||||
GSE94000 |
Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-Cell Acute Lymphoblastic Leukemia
|
5 |
|
Richard A Young | Mar 15, 2017 |